Inventor · disambiguated record
Edward Rockenstein
Also filed as: ROCKENSTEIN EDWARD · ROCKENSTEIN EDWARD M
15 granted patents·11 pending applications·204 citations·filing 1998–2024
93Inventor score
Top patents by PatentIndex Score
26 records- 0194US8092801B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Jan 10, 2012·44 cites·15 claims
- 0294US7919088B2Treatment and delay of onset of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2007·Granted Apr 5, 2011·40 cites·15 claims
- 0393US8147833B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2008·Granted Apr 3, 2012·18 cites·4 claims
- 0491US8506959B2Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2005·Granted Aug 13, 2013·13 cites·15 claims
- 0588US8450481B2Compounds for inhibiting protein aggregation, and methods for making and using themMASLIAH ELIEZER·Filed 2008·Granted May 28, 2013·8 cites·13 claims
- 0683US9034337B2Treatment and delay of outset of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2007·Granted May 19, 2015·7 cites·15 claims
- 0782US8846682B2Compound suitable for the treatment of synucleopathiesMASLIAH ELIEZER·Filed 2010·Granted Sep 30, 2014·8 cites·3 claims
- 0881US6107477ANon-optimal Kozaks sequencesAURORA BIOSCIENCES CORP·Filed 1998·Granted Aug 22, 2000·47 cites·20 claims
- 0976US10947302B2Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using themUNIV CALIFORNIA·Filed 2017·Granted Mar 16, 2021·1 cites·18 claims
- 1075US7393994B2Transgenic mouse model for neurodegenerative diseasesUNIV CALIFORNIA·Filed 2001·Granted Jul 1, 2008·14 cites·20 claims
- 1173US8946165B2Compounds for reversing and inhibiting protein aggregation, and methods for making and using themMASLIAH ELIEZER·Filed 2009·Granted Feb 3, 2015·1 cites·16 claims
- 1270US2021032318A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 1368US2024254211A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 1466US2019300598A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 1562US2017349651A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2017·Application pending·0 cites
- 1661US7795495B2Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using themUNIV CALIFORNIA·Filed 2007·Granted Sep 14, 2010·0 cites·6 claims
- 1759US2012201842A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseSCHENK DALE B·Filed 2012·Application pending·0 cites
- 1856US2016060331A1Prevention and treatment of synucleinopathic and amyloidogenic diseasePROTHENA BIOSCIENCES LTD·Filed 2015·Application pending·0 cites
- 1955US2012142902A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseSCHENK DALE B·Filed 2011·Application pending·0 cites
- 2053US2008014194A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseELAN PHARM INC·Filed 2007·Application pending·0 cites
- 2151US2014364610A1Compound suitable for the treatment of synucleopathiesNEUROPORE THERAPIES INC·Filed 2014·Application pending·0 cites
- 2250US2010031377A1Prevention and treatment of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2005·Application pending·0 cites
- 2347US7459601B2Human α synuclein expressing transgenic miceUNIV CALIFORNIA·Filed 2004·Granted Dec 2, 2008·0 cites·14 claims
- 2447US2016184416A1Prevention and Treatment of Synucleinopathic and Amyloidogenic DiseaseSCHENK DALE B·Filed 2015·Application pending·0 cites
- 2544US7276643B2Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agentsUNIV CALIFORNIA·Filed 2001·Granted Oct 2, 2007·0 cites·7 claims
- 2634US7226746B1Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative diseaseUNIV CALIFORNIA·Filed 1999·Granted Jun 5, 2007·3 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →